Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Cardiovascular Event Risk in Rheumatoid Arthritis is Higher than in Type 2 Diabetes: a 15 Year Longitudinal Study.

Agca R, Hopman LHGA, Laan KCJ, van Halm VP, Peters MJL, Smulders YM, Dekker JM, Nijpels G, Stehouwer CDA, Voskuyl AE, Boers M, Lems WF, Nurmohamed MT.

J Rheumatol. 2019 May 15. pii: jrheum.180726. doi: 10.3899/jrheum.180726. [Epub ahead of print]

PMID:
31092721
2.

The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis.

Heslinga SC, Konings TC, van der Horst-Bruinsma IE, Kamp O, van Halm VP, de Bruin-Bon H, Peters MJ, Nurmohamed MT.

Biologics. 2018 Nov 8;12:143-149. doi: 10.2147/BTT.S176806. eCollection 2018.

3.

Assessment of aortic stiffness in patients with ankylosing spondylitis using cardiovascular magnetic resonance.

Biesbroek PS, Heslinga SC, van de Ven PM, Peters MJL, Amier RP, Konings TC, Maroules CD, Ayers C, Joshi PH, van der Horst-Bruinsma IE, van Halm VP, van Rossum AC, Nurmohamed MT, Nijveldt R.

Clin Rheumatol. 2018 Aug;37(8):2151-2159. doi: 10.1007/s10067-018-4135-x. Epub 2018 May 12.

PMID:
29754182
4.

Insights into cardiac involvement in ankylosing spondylitis from cardiovascular magnetic resonance.

Biesbroek PS, Heslinga SC, Konings TC, van der Horst-Bruinsma IE, Hofman MBM, van de Ven PM, Kamp O, van Halm VP, Peters MJL, Smulders YM, van Rossum AC, Nurmohamed MT, Nijveldt R.

Heart. 2017 May;103(10):745-752. doi: 10.1136/heartjnl-2016-310667. Epub 2016 Nov 16.

PMID:
27852696
5.

Algorithm-Based Screening May Improve Patient Selection for the Subcutaneous Implantable Defibrillator.

Brouwer TF, Kooiman KM, Olde Nordkamp LR, van Halm VP, Knops RE.

JACC Clin Electrophysiol. 2016 Oct;2(5):605-614. doi: 10.1016/j.jacep.2016.02.011. Epub 2016 May 18.

6.

Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders.

Agca R, Heslinga SC, van Halm VP, Nurmohamed MT.

Heart. 2016 May 15;102(10):790-5. doi: 10.1136/heartjnl-2015-307838. Epub 2016 Feb 17. Review.

PMID:
26888573
7.

Subcutaneous Implantable Cardioverter Defibrillator Lead Failure due to Twiddler Syndrome.

Kooiman KM, Brouwer TF, Van Halm VP, Knops RE.

Pacing Clin Electrophysiol. 2015 Nov;38(11):1369-71. doi: 10.1111/pace.12741. Epub 2015 Sep 22.

PMID:
26306701
8.

Ventricular Fibrillation due to Automated Atrial Threshold Testing in a Patient with an Implantable Cardioverter Defibrillator.

Schellevis MM, VAN Halm VP.

Pacing Clin Electrophysiol. 2015 Nov;38(11):1355-8. doi: 10.1111/pace.12639. Epub 2015 May 4. No abstract available.

PMID:
25851701
9.

Tumor necrosis factor blocking therapy and congestive heart failure in patients with inflammatory rheumatic disorders: a systematic review.

Heslinga SC, Van Sijl AM, De Boer K, Van Halm VP, Nurmohamed MT.

Curr Med Chem. 2015;22(16):1892-902. Review.

PMID:
25666788
10.

Increased progression of carotid intima media thickness in thyroid peroxidase antibodies-positive rheumatoid arthritis patients.

Raterman HG, Voskuyl AE, Simsek S, Schreurs MW, van Hoogstraten IM, Peters MJ, van Halm VP, Dijkmans BA, Lips P, Lems WF, Nurmohamed MT.

Eur J Endocrinol. 2013 Oct 21;169(6):751-7. doi: 10.1530/EJE-13-0394. Print 2013 Dec.

PMID:
24005313
11.

Patients with rheumatoid arthritis have more vulnerable arterial plaques, but lowering disease activity may stabilize this threat.

Van Halm VP.

J Rheumatol. 2013 Apr;40(4):348-9. doi: 10.3899/jrheum.130104. No abstract available.

PMID:
23547252
12.

Different type of carotid arterial wall remodeling in rheumatoid arthritis compared with healthy subjects: a case-control study.

Van Sijl AM, Van Den Hurk K, Peters MJ, Van Halm VP, Nijpels G, Stehouwer CD, Smulders YV, Voskuyl AE, Dekker JM, Nurmohamed MT.

J Rheumatol. 2012 Dec;39(12):2261-6. doi: 10.3899/jrheum.120617. Epub 2012 Oct 1.

PMID:
23027891
13.

Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRÉ Study.

van Sijl AM, van den Oever IA, Peters MJ, Boers M, Dijkmans BA, van Halm VP, Smulders YM, Voskuyl AE, Nurmohamed MT.

Ann Rheum Dis. 2012 Mar;71(3):341-4. doi: 10.1136/annrheumdis-2011-200051. Epub 2011 Sep 27.

PMID:
21953344
14.

Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.

Peters MJ, van Halm VP, Voskuyl AE, Smulders YM, Boers M, Lems WF, Visser M, Stehouwer CD, Dekker JM, Nijpels G, Heine R, Dijkmans BA, Nurmohamed MT.

Arthritis Rheum. 2009 Nov 15;61(11):1571-9. doi: 10.1002/art.24836.

15.

The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study.

Raterman HG, van Eijk IC, Voskuyl AE, Peters MJ, Dijkmans BA, van Halm VP, Simsek S, Lems WF, Nurmohamed MT.

Ann Rheum Dis. 2010 Jan;69(1):39-42. doi: 10.1136/ard.2008.100776.

PMID:
19103637
16.

Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation.

van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M, Stehouwer CD, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Smulders YM, Dijkmans BA, Nurmohamed MT.

Ann Rheum Dis. 2009 Sep;68(9):1395-400. doi: 10.1136/ard.2008.094151. Epub 2008 Aug 12.

PMID:
18697775
17.

Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.

Peters MJ, van Halm VP, Nurmohamed MT, Damoiseaux J, Tervaert JW, Twisk JW, Dijkmans BA, Voskuyl AE.

J Rheumatol. 2008 Aug;35(8):1495-9. Epub 2008 Jun 15.

PMID:
18597411
18.

Increased prevalence of antithyroid antibodies in rheumatoid arthritis (RA) patients with a low prevalence of hormonal alterations.

Raterman HG, Van Halm VP, Voskuyl AE, Simsek S, Dijkmans BA, Nurmohamed MT.

Autoimmunity. 2008 Aug;41(5):337. No abstract available.

PMID:
18578079
19.

Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk.

Raterman HG, van Halm VP, Voskuyl AE, Simsek S, Dijkmans BA, Nurmohamed MT.

Ann Rheum Dis. 2008 Feb;67(2):229-32. Epub 2007 Jun 8.

PMID:
17557891
20.

Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.

Peters MJ, Vis M, van Halm VP, Wolbink GJ, Voskuyl AE, Lems WF, Dijkmans BA, Twisk JW, de Koning MH, van de Stadt RJ, Nurmohamed MT.

Ann Rheum Dis. 2007 Jul;66(7):958-61. Epub 2007 Feb 21.

21.
22.

Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis.

van Halm VP, Nielen MM, Nurmohamed MT, van Schaardenburg D, Reesink HW, Voskuyl AE, Twisk JW, van de Stadt RJ, de Koning MH, Habibuw MR, van der Horst-Bruinsma IE, Dijkmans BA.

Ann Rheum Dis. 2007 Feb;66(2):184-8. Epub 2006 Jun 7.

23.

Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis.

van Halm VP, van Denderen JC, Peters MJ, Twisk JW, van der Paardt M, van der Horst-Bruinsma IE, van de Stadt RJ, de Koning MH, Dijkmans BA, Nurmohamed MT.

Ann Rheum Dis. 2006 Nov;65(11):1473-7. Epub 2006 Apr 27.

24.

Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis.

van Halm VP, Slot MC, Nurmohamed MT, Tervaert JW, Dijkmans BA, Voskuyl AE.

Ann Rheum Dis. 2006 May;65(5):590-4. Epub 2005 Oct 25.

25.

Statin therapy might be beneficial for patients with ankylosing spondylitis.

van Denderen JC, Peters MJ, van Halm VP, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT.

Ann Rheum Dis. 2006 May;65(5):695-6. Epub 2005 Oct 11. No abstract available.

26.

Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.

Nurmohamed MT, van Halm VP, Dijkmans BA.

Drugs. 2002;62(11):1599-609. Review.

PMID:
12109923

Supplemental Content

Loading ...
Support Center